Make an Appointment
HONG Defei
General Surgery-Hepatobiliary and Pancreatic Surgery
Title:Professor/Senior Consultant
Degree/diploma:Ph.D.
Doctoral/master's supervisor:Doctoral supervisor
Areas of focus:
Diagnosis and management of hepatobiliary, pancreatic, and splenic tumors, gastrointestinal tumors with liver metastasis, hepatobiliary and pancreatic stone diseases, abdominal tumors, trauma and other disorders; especially the comprehensive treatment of hepatobiliary and pancreatic malignancies.
Biographical sketch
Dr. HONG Deifei graduated from Zhejiang Medical University in 1992 and obtained his PhD in surgery from Zhejiang University in 2002. He has devoted himself to general surgery for over 30 years, with a particular focus on hepatopancreatobiliary surgery research. The implementation of Dr. Hong's pancreaticoenteric anastomosis can significantly reduce the incidence of postoperative pancreatic fistula. The invention of percutaneous microwave ablation liver partition and portal vein embolization(PAPPL) can serve as a partial alternative to liver transplantation in the treatment of advanced liver cancer. He has edited and co-authored 18 monographs on hepatobiliary and pancreatic surgery and published in excess of 150 papers. He had been responsible for 6 national and provincial medical research projects. Dr. Hong's monograph Clinical Research and Application of Laparoscopic Technique in Hepatobiliary, Pancreatic and Splenic Surgery won the second prize of the National Scientific and Technological Progress Award. He had been invited as a visiting scholar by renowned international hospitals, including Johns Hopkins Hospital in the United States and the University of Tokyo Hospital in Japan.
The internationally pioneering treatment scheme combining chemotherapy with traditional Chinese medicine proposed by Dr. Hong is considered one of the most effective current treatment strategies for pancreatic cancer. He was conferred the title of Chief Expert in Pancreatic Cancer at Shanghai Mengchao Cancer Medical Center by Dr. WU Mengchao, an academician of the Chinese Academy of Sciences, in recognition of his outstanding accomplishments in pancreatic cancer. He has been invited to provide consultations on complex hepatobiliary and pancreatic surgeries in over 130 hospitals across 30 provinces and cities.
Professional memberships
Specialist of the Chinese Academy of Engineering
Commissioner of the Biliary Surgery Group of the Chinese Society of Surgery, Chinese Medical Association
Leader of the Minimally Invasive Surgery Group of the Pancreatic Disease Committee, Chinese Research Hospital Association
Chairman of the Multi-disciplinary Diagnosis and Treatment of Gastrointestinal Tumors of the Zhejiang Society for Mathematical Medicine
